Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

References for PMC Articles for PubMed (Select 19395420)

1.

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study.

Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer S, Cuzick J, van Ballegooijen M, Clavel C, Iftner T; Joint European Cohort Study.

BMJ. 2008 Oct 13;337:a1754. doi: 10.1136/bmj.a1754.

2.

Does lowering the screening age for cervical cancer in The Netherlands make sense?

van der Aa MA, de Kok IM, Siesling S, van Ballegooijen M, Coebergh JW.

Int J Cancer. 2008 Sep 15;123(6):1403-6. doi: 10.1002/ijc.23652.

PMID:
18566998
3.

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.

McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, Skegg DC.

Lancet Oncol. 2008 May;9(5):425-34. doi: 10.1016/S1470-2045(08)70103-7. Epub 2008 Apr 11.

PMID:
18407790
4.

Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands.

Rebolj M, van Ballegooijen M, Berkers LM, Habbema D.

Int J Cancer. 2007 Feb 15;120(4):806-12.

PMID:
17131311
5.

Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies.

Koliopoulos G, Arbyn M, Martin-Hirsch P, Kyrgiou M, Prendiville W, Paraskevaidis E.

Gynecol Oncol. 2007 Jan;104(1):232-46. Epub 2006 Nov 3. Review.

PMID:
17084886
6.

Incidence of cervical cytological abnormalities with aging in the women's health initiative: a randomized controlled trial.

Yasmeen S, Romano PS, Pettinger M, Johnson SR, Hubbell FA, Lane DS, Hendrix SL.

Obstet Gynecol. 2006 Aug;108(2):410-9.

PMID:
16880313
7.

American Cancer Society guidelines for the early detection of cancer, 2006.

Smith RA, Cokkinides V, Eyre HJ.

CA Cancer J Clin. 2006 Jan-Feb;56(1):11-25; quiz 49-50. Review.

PMID:
16449183
8.

The epidemiology of genital human papillomavirus infection.

Trottier H, Franco EL.

Vaccine. 2006 Mar 30;24 Suppl 1:S1-15. Review.

PMID:
16406226
9.

Cervical human papillomavirus screening among older women.

Grainge MJ, Seth R, Guo L, Neal KR, Coupland C, Vryenhoef P, Johnson J, Jenkins D.

Emerg Infect Dis. 2005 Nov;11(11):1680-5.

10.

Age-specific incidence and clearance of high-risk human papillomavirus infections in women in the former Soviet Union.

Syrjänen S, Shabalova I, Petrovichev N, Podistov J, Ivanchenko O, Zakharenko S, Nerovjna R, Kljukina L, Branovskaja M, Juschenko A, Tosi P, Syrjänen K; NIS Cohort Study Group.

Int J STD AIDS. 2005 Mar;16(3):217-23.

PMID:
15835076
11.

Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.

Coldman A, Phillips N, Kan L, Matisic J, Benedet L, Towers L.

J Med Screen. 2005;12(1):7-11.

PMID:
15814014
12.

Cervical cancer screening programmes and policies in 18 European countries.

Anttila A, Ronco G, Clifford G, Bray F, Hakama M, Arbyn M, Weiderpass E.

Br J Cancer. 2004 Aug 31;91(5):935-41.

13.

Cervical screening in women over the age of 50: results of a population-based multicentre study.

Flannelly G, Monaghan J, Cruickshank M, Duncan I, Johnson J, Jordan J, Campbell M, Patnick J.

BJOG. 2004 Apr;111(4):362-8.

PMID:
15008774
14.

Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women.

Baay MF, Smits E, Tjalma WA, Lardon F, Weyler J, Van Royen P, Van Marck EA, Vermorken JB.

Int J Cancer. 2004 Jan 10;108(2):258-61.

PMID:
14639612
15.

Screening for cervical cancer: recommendations and rationale.

U.S. Preventive Services Task Force.

Am J Nurs. 2003 Nov;103(11):101-2, 105-6, 108-9. No abstract available.

PMID:
14625432
16.
17.

Low risk of cervical cancer during a long period after negative screening in the Netherlands.

van den Akker-van Marle ME, van Ballegooijen M, Habbema JD.

Br J Cancer. 2003 Apr 7;88(7):1054-7.

18.

Influences on the risk of recurrent high grade cervical abnormality.

Mitchell H, Hocking J.

Int J Gynecol Cancer. 2002 Nov-Dec;12(6):728-34.

PMID:
12445250
19.

Age-specific differences in treatment and survival of patients with cervical cancer in the southeast of The Netherlands, 1986-1996.

de Rijke JM, van der Putten HW, Lutgens LC, Voogd AC, Kruitwagen RF, van Dijck JA, Schouten LJ.

Eur J Cancer. 2002 Oct;38(15):2041-7.

PMID:
12376210
20.

Early discharge of low-risk women from cervical screening.

Ogilvie D.

J Public Health Med. 2001 Dec;23(4):272-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk